praxis pharmaceuticals inc which owns worldwide licensing rights promising aids treatment al721 said large scale tests drug planned for this summer united states arnold lippa praxis president said praxis will test drug few hundred patients with full blown aids those with aids related complex precursor aids and more patients with swollen lymph glands but aids symptoms praxis reported net loss 186 000 dlrs for year ended june 1986 lippa said firm has about two mln dlrs left from its public offering january 1985 but lippa expects easily spend five mln dlrs these new clinical trials said beverly hills calif based company preparing private offering and discussing ventures with pharmaceutical firms help finance cost trials another mark interest al721 anthony fauci heads national institute allergy and infectious disease said government will testing al721 its aids treatment evaluation units june spokeswoman said study will small and will establish drug toxicity said study will expedited allow next phase testing proceed rapidly these plans completion small scale test drug effectiveness patients with aids related lymphadenopathy swollen lymph glands lukes roosevelt hospital new york and another study aids patients israel drug was developed reuter 